Type 5 17β-hydroxysteroid dehydrogenase/prostaglandin F synthase (AKR1C3): Role in breast cancer and inhibition by non-steroidal anti-inflammatory drug analogs-Reference-Cited by-同舟云学术

Type 5 17β-hydroxysteroid dehydrogenase/prostaglandin F synthase (AKR1C3): Role in breast cancer and inhibition by non-steroidal anti-inflammatory drug analogs

Published:2009-03 Issue:1-3 Volume:178 Page:221-227
ISSN:0009-2797
Container-title:Chemico-Biological Interactions
language:en
Short-container-title:Chemico-Biological Interactions

Author:

Byrns Michael C.,Penning Trevor M.

Publisher

Elsevier BV

Subject

Toxicology,General Medicine

Reference32 articles.

1. Intracrinology: role of the family of 17β-hydroxysteroid dehydrogenases in human physiology and disease;Labrie;J. Mol. Endocrinol.,2000

2. Sex steroid-producing enzymes in human breast cancer;Suzuki;Endocr. Relat. Cancer,2005

3. Human 3α-hydroxysteroid dehydrogenase isoforms (AKR1C1-AKR1C4) of the aldo-keto reductase superfamily: functional plasticity and tissue distribution reveals roles in the inactivation and formation of male and female sex hormones;Penning;Biochem. J.,2000

4. Characteristics of a highly labile human type 5 17β-hydroxysteroid dehydrogenase;Dufort;Endocrinology,1999

5. Deoxycorticosterone inactivation by AKR1C3 in human mineralocorticoid target tissues;Sharma;Mol. Cell Endocrinol.,2006

Cited by 67 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fenamates: Forgotten treasure for cancer treatment and prevention: Mechanisms of action, structural modification, and bright future;Medicinal Research Reviews;2024-08-22

2. Indomethacin Derivatives as Potential Anticancer Agents ‐ Daybreak of New Epoch;ChemistrySelect;2024-08-08

3. Pregnane X receptor (PXR) deficiency promotes hepatocarcinogenesis via induction of Akr1c18 expression and prostaglandin F2α (PGF2α) levels;Biochemical Pharmacology;2024-07

4. AKR1C3 in carcinomas: from multifaceted roles to therapeutic strategies;Frontiers in Pharmacology;2024-03-08

5. Inhibition of aldo-keto reductase 1C3 overcomes gemcitabine/cisplatin resistance in bladder cancer;Chemico-Biological Interactions;2024-01